Feng Luo

机构：Sichuan University, West China Hospital of Sichuan University, CCCC Highway Consultants (China) · ORCID：0009-0006-9343-0721

发表论文 72 篇 · 总被引 959 次 · h-index 15

代表论文

• Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study (2024 · Journal of Clinical Oncology · 被引 213)
• Mitophagy: A key regulator of radiotherapy resistance in the tumor immune microenvironment (2025 · Molecular Aspects of Medicine · 被引 22)
• Intrapleural pressure-controlled piezo-catalytic nanozyme for the inhibition of malignant pleural effusion (2025 · Nature Communications · 被引 11)
• Inflammatory markers mediate the association between alternative adiposity indices and mortality in patients with rheumatoid arthritis: data from NHANES 1999–2018 (2025 · Lipids in Health and Disease · 被引 7)
• Homeostatic Measure of Insulin Resistance Is Associated With Future Asthma Exacerbations: A 1-Year Prospective Cohort Study (2024 · The Journal of Allergy and Clinical Immunology In Practice · 被引 6)
• Efficacy and safety of glucocorticoids in the treatment of COVID-19: a systematic review and meta-analysis of RCTs (2024 · Clinical and Experimental Medicine · 被引 5)